Twenty-year outcome in neovascular age-related macular degeneration treated with photodynamic therapy and intravitreal bevacizumab/ranibizumab injections: A case report-Reference-Cited by-同舟云学术

Twenty-year outcome in neovascular age-related macular degeneration treated with photodynamic therapy and intravitreal bevacizumab/ranibizumab injections: A case report

Published:2023-06 Issue: Volume:42 Page:103349
ISSN:1572-1000
Container-title:Photodiagnosis and Photodynamic Therapy
language:en
Short-container-title:Photodiagnosis and Photodynamic Therapy

Author:

Lin Zhuangling^ORCID,Zhou Lijun,Huang Chuangxin,Li Zijing,Lu Tu,Cong Qifeng,Liang Jiandong,Zhong Xiaojing,Lu Lin,Jin Chenjin^ORCID

Funder

Natural Science Foundation of Guangdong Province

Guangzhou Municipal Science and Technology Project

Publisher

Elsevier BV

Subject

Pharmacology (medical),Dermatology,Oncology,Biophysics

Reference11 articles.

1. Ten-year real-world outcomes of anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration;Cheema;Clin. Ophthalmol.,2021

2. Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration;Upasani;Indian J. Ophthalmol.,2021

3. Comparison of visual outcomes of polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration-up to 10 years of follow-up;Park;Acta Ophthalmol.,2022

5. Rescue photodynamic therapy for age-related macular degeneration refractory to anti-vascular endothelial growth factor monotherapy;Yoshida;Photodiagn. Photodyn. Ther.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photodynamic Therapy: From the Basics to the Current Progress of N-Heterocyclic-Bearing Dyes as Effective Photosensitizers;Molecules;2023-06-29